Humana (HUM) analyst forecast and price target
Analyst forecast
Consensus of 30 analyst ratings
Based on 13 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Mizuho | Maintained | Outperform | $495.00 from $468.00 | Oct 13, 2026 |
| Raymond James | Upgraded | Market Perform → Outperform | $520.00 | Oct 12, 2026 |
| Oppenheimer | Maintained | Outperform | $525.00 from $475.00 | Oct 12, 2026 |
| Truist Securities | Maintained | Hold | $475.00 from $415.00 | Oct 12, 2026 |
| UBS | Maintained | Neutral | $495.00 from $405.00 | Oct 12, 2026 |
| Baird | Upgraded | Neutral → Outperform | $596.00 from $390.00 | Oct 9, 2026 |
| Oppenheimer | Maintained | Outperform | $475.00 from $405.00 | Oct 9, 2026 |
| Barclays | Maintained | Overweight | $582.00 from $515.00 | Oct 9, 2026 |
| Cantor Fitzgerald | Upgraded | Neutral → Overweight | $460.00 from $300.00 | Oct 7, 2026 |
| Barclays | Upgraded | Equal-Weight → Overweight | $515.00 from $407.00 | Sep 25, 2026 |
| JP Morgan | Maintained | Neutral | $393.00 from $316.00 | Aug 10, 2026 |
| Morgan Stanley | Upgraded | Underweight → Equal-Weight | $370.00 from $249.00 | Aug 5, 2026 |
| Barclays | Maintained | Equal-Weight | $407.00 from $344.00 | Jul 31, 2026 |
| TD Cowen | Maintained | Hold | $370.00 from $350.00 | Jul 31, 2026 |
| Raymond James | Downgraded | Outperform → Market Perform | — | Jul 30, 2026 |
| Evercore ISI Group | Upgraded | In-Line → Outperform | $480.00 from $430.00 | Jul 30, 2026 |
| Guggenheim | Maintained | Buy | $471.00 from $269.00 | Jul 30, 2026 |
| UBS | Maintained | Neutral | $405.00 from $320.00 | Jul 30, 2026 |
| Truist Securities | Maintained | Hold | $415.00 from $320.00 | Jul 14, 2026 |
| TD Cowen | Maintained | Hold | $350.00 from $211.00 | Jul 14, 2026 |
Frequently asked questions
What is the price target for HUM stock?
The average 12-month analyst price target for Humana (HUM) is $479.38, with a high estimate of $596.00 and a low of $370.00, across 13 analysts.
Is HUM a buy, sell, or hold?
Analysts covering Humana currently average a Buy rating: 16 buy, 13 hold and 1 sell, from 30 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for HUM?
The average price target of $479.38 implies 12.16% upside from the last price of $427.40.
What is the latest analyst rating on HUM?
On Oct 13, 2026, Mizuho maintained Humana at Outperform with a price target of $495.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.